Microbiology Archives

T2Bacteria® Panel: It’s the first FDA-cleared and CE-marked test panel capable of identifying six common bacterial pathogens.
Time Efficiency: Delivers results in 3 to 5 hours directly from a whole blood sample.
Pathogens Detected: Includes E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and E. coli.
Clinical Relevance: These bacteria are prevalent in emergency departments and are often responsible for hospital-acquired infections.
ESKAPE Pathogens: Some detected species are ESKAPE pathogens, known for their virulence and resistance to empiric antimicrobial therapy.
Impact on Patient Care: Quick identification of these pathogens is crucial for timely and targeted treatment, which can significantly improve patient outcomes.
90% Sensitivity
98% Specificity

Innovation: The T2Dx Instrument represents a breakthrough in diagnostic technology, enabling direct detection from whole blood samples.
Automation: Fully automated system with walk-away operation, minimising human intervention once the test is set up.
Efficiency: Can run multiple tests simultaneously directly from whole blood, without prior sample preparation.
Capabilities: The T2Dx Instrument provides rapid results, within 3 to 5 hours.
User-Friendly: Simple user interface with a touchscreen display. Step-by-step text and illustrative prompts for easy operation.
Versatility: The instrument can run various tests, including the HSA-registered T2Bacteria and T2Candida Panels